Results 231 to 240 of about 140,652 (287)

Beta-thalassemia [PDF]

open access: yesGenetics in Medicine, 2010
Beta-thalassemias are a group of hereditary blood disorders characterized by anomalies in the synthesis of the beta chains of hemoglobin resulting in variable phenotypes ranging from severe anemia to clinically asymptomatic individuals. The total annual incidence of symptomatic individuals is estimated at 1 in 100,000 throughout the world and 1 in 10 ...
Renzo Galanello, Antonio Cao
exaly   +5 more sources
Some of the next articles are maybe not open access.

Related searches:

Thalassemia in India

Hemoglobin, 2022
Management and control of hemoglobinopathies are a challenge in India where 67.0% of people reside in rural regions. The GDP spent on health is one of the lowest (1.3%) resulting in high out-of-pocket expenses. The β-thalassemias are prevalent with an estimated 7500-12000 new births each year. Hb S (HBB: c.20A>T) and Hb E (HBB: c.79G>A) are also common
Roshan B, Colah, Tulika, Seth
openaire   +2 more sources

Thalassemia

Hematology, 2004
Abstract New developments in the epidemiology, treatment and prognosis of thalassemia have dramatically altered the approach to the care of affected patients, and these developments are likely to have an even greater impact in the next few years.
Alan R, Cohen   +4 more
openaire   +2 more sources

Thalassemia in Indonesia

Hemoglobin, 2022
Indonesia is located along the 'Thalassemia Belt' and a hotspot for hemoglobinopathies. Around 3.0-10.0% of the population carry β-thalassemia (β-thal) and 2.6-11.0% of the population carry α-thalassemia (α-thal). It is estimated that around 2500 babies are born with β-thal major (β-TM) each year.
Pustika A. Wahidiyat   +8 more
openaire   +2 more sources

Thalassemias

Pediatric Clinics of North America, 2013
The thalassemia syndromes are hemoglobin disorders that result from significantly reduced or absent synthesis of either the α- or β-globin chains. The result is a chronic hemolytic anemia with ineffective erythropoiesis and bone marrow overstimulation.
Alissa, Martin, Alexis A, Thompson
openaire   +2 more sources

β-Thalassemia

open access: yesGenetics in Medicine, 2017
β-Thalassemia is caused by reduced (β +) or absent (β 0) synthesis of the β-globin chains of hemoglobin. Three clinical and hematological conditions of increasing severity are recognized: the β-thalassemia carrier state, thalassemia intermedia, and ...
Raffaella Origa
exaly   +2 more sources

Fractures in thalassemia

The Journal of Bone & Joint Surgery, 1976
Fractures occur frequently in patients with homozygous beta-thalassemia. A study was made of the fractures noted in a group of patients who were followed at the Thalassemia Clinic at The New York Hospital-Cornell Medical Center. Results indicate that these patients often sustain fractures which are multiple and which frequently heal with resultant ...
D M, Dines, V C, Canale, W D, Arnold
openaire   +2 more sources

Thalassemia in Thailand

Hemoglobin, 2022
Thailand has a population of 66.2 million with 30.0-40.0% of them carrying thalassemia genes. Interaction of these thalassemia genes lead to more than 60 genotypes with a wide spectrum of clinical severity from asymptomatic to lethal. Estimation based on gene frequencies and number of babies born each year, there will be about 1.2% babies born with ...
Kittiphong Paiboonsukwong   +3 more
openaire   +2 more sources

Alpha‐thalassemia

American Journal of Hematology, 1977
AbstractThe current concepts of α‐thalassemia including incidence, genetics, clinical spectrum and diagnosis are reviewed. Speculation concerning clinical application of the molecular biology of α‐thalassemia is also presented.
J G, Adams, M H, Steinberg
openaire   +2 more sources

Home - About - Disclaimer - Privacy